Saba Javed/LinkedIn
Aug 10, 2026, 04:33
Saba Javed: Managing VTE in Cancer Patients With Thrombocytopenia
Saba Javed, Assistant Manager, Cystic Fibrosis Clinical Pharmacist and Pediatric Infectious Disease Clinical Pharmacist at The Indus Hospital, shared a post on LinkedIn:
“I am currently reviewing many PICU oncology patients who are being treated with TLS, some of whom are undiagnosed or battling cancer.
It is well-known that oncology patients often have neutropenia and low platelet counts. I am interested in understanding how to manage cases where they develop VTE.
I came across a very informative article that specifies platelet count thresholds for administering or withholding treatment, specifically concerning LMWH (Enoxaparin).
Sharing a quick chart to review.”
Stay updated with Hemostasis Today.
-
Aug 10, 2026, 05:45Colin Holburn: Key Laboratory Clues to End Organ Damage
-
Aug 10, 2026, 05:35George Dimitrov: SII and Cancer – What Can This Marker Really Tell Us
-
Aug 10, 2026, 05:01Emicizumab and Breastfeeding New Clinical Evidence – JTH
-
Aug 10, 2026, 04:53Abdulaziz Elnusiry: Pulmonary Embolism – The Silent Emergency We Need to Talk About
-
Aug 10, 2026, 04:21Heghine Khachatryan: When Cancer Is Not Enough to Predict VTE Risk
-
Aug 10, 2026, 04:09Ney Carter Borges: How Polyphenols Influence Endothelial Function
-
Aug 10, 2026, 03:54Maria Cherska: One Pill, Better Adherence, Same LDL-C Control
-
Aug 10, 2026, 02:41Edward Lee Carter: Can Anticoagulation Be Safely De-Escalated After AF Ablation?
-
Aug 9, 2026, 18:10James P. Crowley: How Turmeric and Green Tea May Affect Blood Sugar and Blood Pressure